Brendan Allgood, chief technology officer of AI-driven drug discovery firm Numerate, chats with CW's Vincent Valk about AI's role in pharma and pharma ingredients, including how AI can complement chemistry and what AI can't do. Live from CPhI North America in Chicago.
